Biocon stock hovers around 52-week low as its Malyasian facility undergoes inspection
Updated : July 08, 2019 04:29 PM IST
Biocon hovered around its 52-week low reacting to news of 12 observations being issued across three units — drug substance, drug product, device assembly — of the company’s Malaysian facility.
The management seems confident about the 12 observations, saying that they are procedural with no data integrity issues.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more